Episode 6

full
Published on:

26th Feb 2025

Jenn's Story of Managing MCAS, EDS and POTS

Jenn from Canada shared her experience with mast cell activation syndrome (MCAS) and Ehlers-Danlos syndrome (EDS). She described experiencing symptoms of disautonomia and dislocations from a young age. Her health challenges worsened during her teen years with symptoms such as mold exposure, recurrent hospitalizations for mystery illnesses, and autoimmune-related issues. It wasn't until two years ago that she was diagnosed with MCAS after discovering hidden mold in her home. After consulting with an allergist and starting on a personalized treatment cocktail, including low-dose naltrexone (LDN), she noticed improvements in her chronic headaches, sleep, and other symptoms. The LDN helped alleviate her symptoms more than she expected and significantly improved her quality of life.

Listen for free

Show artwork for The LDN Radio Show About Low Dose Naltrexone

About the Podcast

The LDN Radio Show About Low Dose Naltrexone
Listen to LDN Prescribers, Researchers, Pharmacists from around the world! This is your chance to ask your questions to the experts, please email linda.ldnrt@gmail.com if you have any questions.
Listen to LDN Prescribers, Researchers, Pharmacists from around the world discuss Low Dose Naltrexone.

This is your chance to ask your questions to the experts, please email linda@ldnrt.org with your questions.

The LDN Radio Show is FREE if you would like to make a donation please visit www.ldnresearchtrust.org/donate

About your host

Profile picture for Linda Elsegood

Linda Elsegood

Linda is the founder of the LDN Research Trust established in 2004. She runs the trust raising awareness of LDN, answering with the help of the medical adviser’s, questions from users and the medical profession, helping people around the world find an LDN prescribing doctor. Linda has interviewed so far over 320 LDN Prescribing Doctors, Scientists and Users. Linda has MS and has been taking LDN with great success for MS over the last 10 years.